Literature DB >> 32679522

Pain-related anxiety, sex, and co-use of alcohol and prescription opioids among adults with chronic low back pain.

Lisa R LaRowe1, Jessica M Powers1, Lorra Garey2, Andrew H Rogers2, Michael J Zvolensky2, Joseph W Ditre3.   

Abstract

BACKGROUND: Both alcohol and prescription opioid use/misuse are highly prevalent among individuals with chronic pain. Co-use of alcohol and prescription opioids is also common, despite contraindications due to increased risk of negative health effects and mortality. There is evidence that pain-related anxiety (i.e., the tendency to respond to pain with anxiety or fear) may be associated with heavier drinking and prescription opioid use/co-use, and that these associations may be especially salient among men.
METHODS: This study is the first examination of pain-related anxiety in relation to hazardous alcohol use, prescription opioid use/misuse, and alcohol-opioid co-use. Participants included 1812 adults with chronic low back pain (69 % female, Mage = 43.95) who completed an online survey assessing health behaviors.
RESULTS: Pain-related anxiety was positively associated with indices of alcohol (i.e., alcohol-related consequences) and opioid use (i.e., prescription opioid use/misuse, daily opioid consumption). Of note, sex moderated associations between pain-related anxiety and both alcohol-related consequences and prescription opioid misuse. In addition to being associated with alcohol and prescription opioid use, independently, pain-related anxiety was also associated with greater likelihood of endorsing co-use of alcohol and opioids and engaging in concurrent hazardous drinking and prescription opioid misuse.
CONCLUSIONS: These findings contribute to a growing literature suggesting that pain-related anxiety is an important transdiagnostic factor in pain and alcohol and prescription opioid use/co-use, perhaps especially among males.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcohol; Chronic pain; Co-Use; Opioids; Pain

Mesh:

Substances:

Year:  2020        PMID: 32679522      PMCID: PMC7423687          DOI: 10.1016/j.drugalcdep.2020.108171

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  52 in total

1.  Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors.

Authors:  Kathleen W Saunders; Michael Von Korff; Cynthia I Campbell; Caleb J Banta-Green; Mark D Sullivan; Joseph O Merrill; Constance Weisner
Journal:  J Pain       Date:  2012-01-29       Impact factor: 5.820

Review 2.  Alcohol and Opioid Use, Co-Use, and Chronic Pain in the Context of the Opioid Epidemic: A Critical Review.

Authors:  Katie Witkiewitz; Kevin E Vowles
Journal:  Alcohol Clin Exp Res       Date:  2018-02-06       Impact factor: 3.455

3.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.

Authors:  J Ware; M Kosinski; S D Keller
Journal:  Med Care       Date:  1996-03       Impact factor: 2.983

4.  Effects of experimental pain induction on alcohol urge, intention to consume alcohol, and alcohol demand.

Authors:  Dezarie Moskal; Stephen A Maisto; Martin De Vita; Joseph W Ditre
Journal:  Exp Clin Psychopharmacol       Date:  2018-01-11       Impact factor: 3.157

5.  Smokers with pain are more likely to report use of e-cigarettes and other nicotine products.

Authors:  Jessica M Powers; Bryan W Heckman; Lisa R LaRowe; Joseph W Ditre
Journal:  Exp Clin Psychopharmacol       Date:  2019-11-14       Impact factor: 3.157

6.  Exploring the Psychometric Properties of the Current Opioid Misuse Measure Among Adults With Chronic Pain and Opioid Use.

Authors:  Andrew H Rogers; Matthew W Gallagher; Robert N Jamison; Michael J Zvolensky
Journal:  Clin J Pain       Date:  2020-08       Impact factor: 3.442

7.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.

Authors:  J B Saunders; O G Aasland; T F Babor; J R de la Fuente; M Grant
Journal:  Addiction       Date:  1993-06       Impact factor: 6.526

8.  Prevalence and characteristics of chronic pain in patients admitted to an outpatient drug and alcohol treatment program.

Authors:  Robert Sheu; David Lussier; Andrew Rosenblum; Chunki Fong; Jason Portenoy; Herman Joseph; Russell K Portenoy
Journal:  Pain Med       Date:  2008-03-11       Impact factor: 3.750

9.  The Pain Anxiety Symptoms Scale: development and validation of a scale to measure fear of pain.

Authors:  Lance M McCracken; Claudia Zayfert; Richard T Gross
Journal:  Pain       Date:  1992-07       Impact factor: 6.961

10.  Are Mechanical Turk worker samples representative of health status and health behaviors in the U.S.?

Authors:  Kelly Walters; Dimitri A Christakis; Davene R Wright
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240

View more
  4 in total

1.  Differences and Correlations of Anxiety, Sleep Quality, and Pressure-Pain Threshold between Patients with Chronic Low Back Pain and Asymptomatic People.

Authors:  Changming Xu; Zhiwei Fu; Juan Wang; Bao Wu; Xue-Qiang Wang
Journal:  Pain Res Manag       Date:  2022-05-17       Impact factor: 2.667

2.  A measure of expectancies for alcohol analgesia: Preliminary factor analysis, reliability, and validity.

Authors:  Lisa R LaRowe; Stephen A Maisto; Joseph W Ditre
Journal:  Addict Behav       Date:  2021-01-08       Impact factor: 3.913

3.  Medications and Patient Factors Associated With Increased Readmission for Alcohol-Related Diagnoses.

Authors:  Joseph C Osborne; Susan E Horsman; Kristin C Mara; Thomas C Kingsley; Robert W Kirchoff; Jonathan G Leung
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-12-20

Review 4.  Cognitive-Affective Transdiagnostic Factors Associated With Vulnerability to Alcohol and Prescription Opioid Use in the Context of Pain.

Authors:  Emily L Zale; Jessica M Powers; Joseph W Ditre
Journal:  Alcohol Res       Date:  2021-07-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.